Exhibit 107
Calculation of Filing Fee Tables
FORM S-1
(Form Type)
Cyclacel Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price(1)(2) | Fee Rate | Amount of Registration Fee | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||||||||||||||||||||
| Newly Registered Securities | ||||||||||||||||||||||||||||||||||||||||||
| Fees to Be Paid | Equity | Common stock, par value $0.001 | 457(o) | $ | 10,000,000 | $ | 0.0001476 | $ | 1,476.00 | |||||||||||||||||||||||||||||||||
| Fees to Be Paid | Equity | Common Stock Warrants to purchase shares of common stock(3) | 457(g) | — | — | $ | 0 | |||||||||||||||||||||||||||||||||||
| Fees to Be Paid | Equity | Common stock issuable upon exercise of the Common Stock Warrants | 457(o) | $ | 20,000,000 | $ | 0.0001476 | $ | 2,952.00 | |||||||||||||||||||||||||||||||||
| Fees to Be Paid | Equity | Pre-funded warrants to purchase shares of common stock(3)(4) | 457(g) | — | — | $ | 0 | |||||||||||||||||||||||||||||||||||
| Fees to Be Paid | Equity | Common Stock issuable upon exercise of the pre-funded warrants(4) | 457(g) | — | — | $ | 0 | |||||||||||||||||||||||||||||||||||
| Carry Forward Securities | ||||||||||||||||||||||||||||||||||||||||||
| Carry Forward Securities | — | — | — | — | — | — | — | — | — | — | — | — | ||||||||||||||||||||||||||||||
| Total Offering Amounts | $ | 30,000,000 | $ | 4,428.00 | ||||||||||||||||||||||||||||||||||||||
| Total Fees Previously Paid | 4,428.00 | |||||||||||||||||||||||||||||||||||||||||
| Total Fee Offsets | — | |||||||||||||||||||||||||||||||||||||||||
| Net Fee Due | $ | 0 | ||||||||||||||||||||||||||||||||||||||||
| (1) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933. |
| (2) | Pursuant to Rule 416, the securities being registered hereunder include such indeterminate number of additional securities as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions. |
| (3) | In accordance with Rule 457(g) under the Securities Act, because the shares of the common stock underlying the warrants are registered hereby, no separate registration fee is required with respect to the warrants registered hereby. |
| (4) | The proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants sold in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock sold in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $10,000,000. |
